IO Biotech (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Industry:Biotech
Business model:B2B

IO Biotech is an immuno-oncology company, focused on the development of vaccine based cancer treatments.

IO Biotech is a spin-out from Center for Cancer Immune Therapy at Herlev Hospital. The company is located at COBIS Science Park in Copenhagen, Denmark.

Investors: we tracked 10 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 184.14M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to IO Biotech

Name Criteria
Denmark Galecto Biotech
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Eir Ventures, Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Denmark Orphazyme
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures, Kurma Life Science Partners
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures, Kurma Life Science Partners
  • At least one other investor: Idinvest Partners
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
60%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures, Novo Seeds
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures
  • Total raised in a similar range: 10M+ USD
France Corlieve Therapeutics
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Kurma Life Science Partners
  • At least one other investor: Idinvest Partners
Denmark Draupnir Bio
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds, Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
50%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Lundbeckfond Ventures, Novo Seeds
  • Total raised in a similar range: 10M+ USD
Top